Evaluation of usefulness of voice guidance for self monitoring blood glucose.

Evaluation of usefulness of voice guidance for self monitoring blood glucose. - Evaluation of usefulness of voice guidance for self monitoring blood glucose.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028482

Enrollment

Registered

2017-08-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients on Insulin therapy/ GLP-1 therapy

Interventions

TERUMO Blood Glucose Monitoring System/MEDISAFE Fit Smile with voice guidance TERUMO Blood Glucose Monitoring System/MEDISAFE Fit Smile

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?Diabetes patient who newly conducts self-monitoring of blood glucose with evaluation object device. (The patient administered with insulin or GLP-1 receptor agonist of type 2 DM.)

Exclusion criteria

Exclusion criteria: ?The patient who has difficulty in understanding of the blood glucose meter by cognitive ability or eyesight drop. ?In addition, the patient whom it was judged an evaluation PI or sub-PI to be unsuitable for evaluation participation.

Design outcomes

Primary

Measure	Time frame
Comparison of the questionnaire result for patient. -Usability,Fisical evaluation,Intension use	—

Secondary

Measure	Time frame
The questionnaire result for Medical staff. (When the study start.)	—

Countries

Japan

Contacts

Public ContactYuki Sonoda

TERUMO CORPORATION Hospital Products Company

yuki_sonoda@terumo.co.jp03-6742-8202

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026